Gain Therapeutics, Inc.GANXNASDAQ
LOADING
|||
Switch Symbol:
Gross Profit Growth Accelerating
Trending higher, above historical average.
Left:
||||
Year-over-year gross profit growth rate
Latest
99.16%
↑ 104% above average
Average (29q)
-2260.25%
Historical baseline
Range
High:99.16%
Low:-32589.87%
Volatility
-1446.3%
Relatively stable
| Period | Value |
|---|---|
| Q3 2025 | 99.16% |
| Q2 2025 | -22.46% |
| Q1 2025 | -10333.66% |
| Q4 2024 | 92.26% |
| Q3 2024 | 93.74% |
| Q2 2024 | -78.16% |
| Q1 2024 | -10375.82% |
| Q4 2023 | 90.58% |
| Q3 2023 | -2.48% |
| Q2 2023 | 90.95% |
| Q1 2023 | -14815.07% |
| Q4 2022 | 99.08% |
| Q3 2022 | 21.00% |
| Q2 2022 | -63.74% |
| Q1 2022 | -5.76% |
| Q4 2021 | 41.64% |
| Q3 2021 | -43.75% |
| Q2 2021 | -32589.87% |
| Q1 2021 | -42.35% |
| Q4 2020 | 36.48% |
| Q3 2020 | 5.07% |
| Q2 2020 | -4.50% |
| Q1 2020 | 0.00% |
| Q4 2019 | -100.00% |
| Q3 2019 | 0.00% |
| Q2 2019 | 0.00% |
| Q1 2019 | 0.00% |
| Q3 2018 | 0.00% |
| Q2 2018 | 0.00% |
| Q1 2018 | 0.00% |